As of December 2024 Intra-Cellular Therapies has a market cap of ₹767.80 Billion. This makes Intra-Cellular Therapies the world's 1851th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 2nd, 2024 the market cap of Intra-Cellular Therapies was reported to be: